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Deglycosylation of viral glycoproteins has been suggested to influence the number of available T cell determinants and
to increase T cell recognition of antigens. In this study, we have investigated whether T cell responses to the HIV-1 envelope
glycoprotein gp160 were influenced by deletion of three N-glycans of the protein. Wild type (wt) and a mutated form of
gp160 (gp160A123) lacking the three N-glycans in the C-terminal CD4-binding region efficiently induced antigen-specific T
cell responses in mice of the H-2b, H-2d, and H-2k haplotypes. Further, T cells primed by either wt gp160 or gp160A123 were
stimulated in vitro to a similar extent by the homologous and heterologous protein, indicating that deletion of the glycans
did not affect the overall immunogenicity and antigenicity of gp160A123 . Wild-type gp160 and gp160A123 induced comparable
T cell responses to those of epitopes which with respect to the secondary structure of gp160 were distant from the deleted
glycans. However, in mice of the H-2b haplotype, wt gp160 primed T cells which responded in vitro to a peptide containing
one of the deleted N-glycosylation sites (Asn448), whereas T cells induced by gp160A123 were unable to recognize this
peptide. Thus, deletion of the glycans abrogated the in vivo priming of T cells recognizing an epitope in close proximity to
the deletion sites. Furthermore, enzymatically deglycosylated gp160 failed to induce a T cell response to this epitope. These
results indicate that the in vivo generation of certain T cell determinants from glycoproteins is dependent on the glycosylation
of the protein. q 1996 Academic Press, Inc.
INTRODUCTION the TCR recognition of the peptide–MHC complex (Hard-
ing et al., 1991; Ishioka et al., 1992; Michae¨lsson et al.,Recognition of protein antigens by the T cell receptor
1994; Thomas et al., 1990).(TCR) on CD4/ T helper cells involves the interaction of
In general, viral envelope proteins are subjected topeptide fragments with class II major histocompatibility
posttranslational modifications, including glycosylation(MHC) molecules on the surface of antigen-presenting
(Doms et al., 1993). The envelope protein gene productcells (APC) (Rudensky et al., 1991; Schwartz, 1985). To
of human immunodeficiency virus (HIV) type 1 is synthe-produce peptides capable of binding to MHC class II
sized as a 160-kDa precursor glycoprotein, gp160, whichmolecules, most antigens have to be processed by the
is proteolytically cleaved into two subunits, gp120 andAPC and in general this event includes proteolytic degra-
gp41 (Ratner et al., 1985). gp120 is extensively glycosyl-dation in endosomes and lysosomes (Unanue, 1992). In
ated, nearly all of the approximately 20 potential N-linkedthis context, the three-dimensional structure of a protein
glycosylation sites in the protein being occupied. Conse-is of considerable importance since it determines the
quently, more than 50% of the molecular weight of gp120accessibility of proteolytic enzymes to cleavage sites,
is constituted by N-linked oligosaccharides (Leonard etthus influencing the array of peptide fragments being
al., 1990; Ratner et al., 1991). N-linked glycans on gp120generated (Atassi et al., 1989; Glimcher et al., 1983;
have been reported to affect the expression of B cellRouas et al., 1993). One property affecting the conforma-
epitopes by modulating the three-dimensional proteintion and in many cases also the proteolytic degradation
conformation (Back et al., 1994; Benjouad et al., 1992,of proteins is the presence of oligosaccharide chains on
1993; Bolmstedt et al., 1992). Glycans also influence Ttheir surface (Rademacher, 1992; Varki, 1993). In addition,
cell recognition of gp120. Botarelli et al. (1991) haveprotein glycans have also been suggested to have effects
shown that 20% of human T cells clones raised to nongly-on T cell activation by interfering with the association
cosylated gp120 failed to respond to the native proteinbetween antigenic peptides and MHC molecules or with
and that recognition most likely was limited by glycans on
the glycosylated gp120. Further, nonglycosylated gp1201 To whom correspondence and reprint requests should be ad-
dressed. Fax: 46-18-50 46 03. was found to induce CD8/ cytotoxic T cell lymphocytes
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more efficiently than the corresponding glycosylated na- (Clayton, Australia). The latter two peptides are analo-
gous to peptide 35 except for a change of Asn448 to Glntive gp120 (Doe et al., 1994).
Considering that complete deglycosylation influences (corresponding to the amino acid substitution in
gp160A123) and Gly (i.e., a nonrelated amino acid), respec-T cell recognition of gp120, we asked whether specific
elimination of selected N-linked glycans would affect the tively (Table 1).
in vivo generation of T cell responses to gp120. To ad-
Preparation of gp160 iscomsdress this issue, we used a mutated version of gp160,
gp160A123 , lacking three N-glycosylation sites in the C- Iscoms containing wt gp160 or gp160A123 were pre-terminal part of the protein (V4–V5 region) (Hemming et
pared by the dialysis method as described by Lo¨vgren
al., 1994). This domain is involved in the binding of gp120
et al. (1987). Briefly, 1 mg of gp160 in phosphate-buffered
to the cellular virus receptor, the CD4 molecule (Dal-
saline (PBS), pH 7.2, containing 2% MEGA-10 (BACHEM,
gleish et al., 1984; Klatzmann et al., 1984), and forms a
Basel, Switzerland) was mixed with 1 mg of cholesterol
complex three-dimensional conformation containing sev-
and 1 mg of phosphatidylcholine in 20% MEGA-10 (w/w in
eral N-glycosylation sites (Freed and Martin, 1994; Fung
H2O) and 10 mg of Quillaja saponins (in H2O) (Spikoside,et al., 1992; Ho et al., 1991a; Lasky et al., 1987; Leonard
Advet AB, Lulea˚, Sweden) in a total volume of 1 ml. The
et al., 1990; Moore et al., 1994; Olshevsky et al., 1990;
mixture was sonicated, incubated at room temperature
Sattentau et al., 1993; Thali et al., 1991). Elimination of
for 60 min, and dialyzed against PBS for 24 hr at room
glycans in the CD4-binding domain of gp120 has pre-
temperature and for 24 hr at 47. After dialysis, the sample
viously been reported not to interfere with essential
was layered on a 10% sucrose cushion in PBS and centri-
events in the virus infectious cycle, such as CD4-binding
fuged in a Kontron TST 41.14 rotor for 18 hr, 207, at 39,000
or the fusion between the virus and cell membrane
rpm. The pelleted material was dissolved in 0.5 ml of
(Bolmstedt et al., 1991; Hemming et al., 1989a, 1994). In
PBS. In line with previous studies (A˚kerblom et al., 1991)
the present study, wild-type (wt) gp160 and gp160A123 recombinant wt gp160 and gp160A123 , each containingwere incorporated into immune-stimulating complexes
the hydrophobic gp41 transmembrane domain, were in-
(iscoms) and used to immunize mice. The capacity of the
corporated into iscoms with high recovery, 80%. Both
wt gp160 and gp160A123 to in vivo prime antigen-specific preparations of gp160 iscoms were analyzed by electron
T cells was determined in in vitro recall experiments and
microscopy for morphology and quality (Ho¨glund et al.,
the specificity of the T cell responses was analyzed using
1989) and the typical cage-like structure of iscoms was
a panel of synthetic peptides representing selected parts
confirmed. The presence of gp160 in the iscoms was
of gp120.
verified by SDS–PAGE using PhastSystem and 5–15%
linear gradient PhastGels (Pharmacia, Uppsala, Sweden)
MATERIALS AND METHODS and both preparations showed one major band corre-
sponding to wt gp160 and gp160A123 . The protein contentAntigens
as determined by amino acid analysis (Aminosyraanalys-
Recombinant vaccinia viruses expressing wt gp160 se- laboratoriet, Uppsala, Sweden) was 0.8 mg/ml in both
quence or a mutated gp160 sequence, gp160A123 , lacking preparations. Quantities of iscoms mentioned in the text
the N-linked glycans associated with Asn406 , Asn448 , and refer to their protein content.
Asn463 , were constructed as previously described using
published protocols for site-directed mutagenesis and Deglycosylation of wt gp160 iscoms
construction of recombinant vaccinia virus (Hemming et
Six micrograms of wt gp160 iscoms was treated withal., 1989a,b, 1994; Hu et al., 1986; Klaniecki et al., 1991).
2.4 U of recombinant N-glycosidase F (Boehringer-Mann-In gp160A123 the mutated asparagine residues were re-
heim, Mannheim, Germany) in 33 ml of 0.03 M phosphateplaced with glutamines. Recombinant gp160 was ex-
buffer, pH 8.0, containing 0.1 M ethylenediaminetetraace-pressed and purified according to Klaniecki et al. (1991).
tic acid (EDTA) (Merck, Darmstadt, Germany), for 36 hr
at 377. As a control, wt gp160 iscoms were incubated forSynthetic peptides
the same time in phosphate buffer containing EDTA but
lacking enzyme. Digestion products were analyzed byThe 13 partially overlapping peptides in Table 1, repre-
senting selected parts of the HIV-1IIIB gp120 sequence SDS–PAGE, and the gels were subsequently transferred
to polyvinyl difluoride membranes (Millipore, Bedford,(Muesing et al., 1985) and with lengths of 17–28 aa, were
synthesized on a solid phase using an Applied Biosystem MA) by electrophoresis as described by Towbin et al.
(1979). gp160 was localized on blots using a monoclonal430A solid-phase peptide synthesizer (Applied Biosys-
tems, Foster City, CA) as previously described (Eriksson antibody directed to the V3 region of gp120 (A˚kerblom
et al., 1990) and with biotinylated concanavalin A lectinet al., 1993; Horal et al., 1991; Vahlne et al., 1991). Peptide
mG5 was purchased from the Department of Medical (Con A) as probes. Bound antibody and lectin were de-
tected with goat anti-mouse IgG (Bio-Rad, Richmond, CA)Chemistry (Biomedical Center, Uppsala, Sweden) and
peptide m67 from Chiron Mimotopes Peptide System and streptavidin (Dakopatts, Glostrup, Denmark), respec-
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TABLE 1
Peptides Representing Selected Parts of the gp120 Sequence
Peptide Amino acidsa Sequenceb Location in gp120
7 90–116 TENFNMWKNDMVEQMHEDIISLWDQSL
8 101–126 VEQMHEDIISLWDQSLKPCVKLTPLC
12 152–176 GEIKNCSFNISTSIRGKVQKEYAFF N-terminal region
15 193–218 LTSCNSVITQACPKVSFEPIPIHYC
16 206–230 PKVSFEPIPIHYCAPAGFAILKCNN
22 283–306 TIIVQLNQSVEINCTRPNNNTRKS V3 region
24 307–326 IRIQRGPGRAFVTIGKIGNMRQAH
31 390–409 LFNSTWFNSTWSTEGSNcNTE
32 401–417 STEGSNNTEGSDTITLP
35 430–453 VGKAMYAPdPISGQIRCSSNITGLL C-terminal region
36 445–466 CSSNITGLLLTRDGGNNNNESE
37 454–476 LTRDGGNNNNESEIFRPGGGDMR
39 477–497 DNWRSELYKYKVVKIEPLGVA
mG5 430–453 VGKAMYAPPISGQIRCSSQITGLL
m67 430–453 VGKAMYAPPISGQIRCSSGITGLL
a Amino acid numbering according to Muesing et al. (1985).
b Amino acid sequence indicated as a one-letter code.
c Underlining indicates asparagines associated with N-glycosylation sites which are deleted in gp160A123.
d Boldface indicates the potential proteolytic cleavage site for cathepsin B in gp160.
tively, conjugated to alkaline phosphatase. The binding Statistics
was visualized using Fast blue B/b-naphtyl phosphate
Results are expressed as mean values { SEM. Un-(Sigma, St. Louis, MO) as substrate.
paired two-tailed t test was used for the comparison
of two mean values, and P  0.05 was considered as
Immunization of mice statistically significant.
Female mice of the inbred strains C57BL/6, BALB/c,
RESULTS
and CBA (H-2b, H-2d, and H-2k, respectively), 8–12 weeks
old, were obtained from the Biomedical Center, Uppsala, T cell response to wt gp160 and gp160A123
Sweden. Groups of two to three mice were immunized
The T cell response to wt gp160 and gp160A123 iscomssubcutaneously at the base of the tail with 2 mg of wt
was analyzed in C57BL/6 (H-2b), BALB/c (H-2d), and CBAgp160, deglycosylated wt gp160, or gp160A123 in iscoms
(H-2k) mice. The proliferative responses in vitro of LN(in 100 ml) and the draining inguinal and periaortic lymph
cells from immunized mice were recorded after criss-nodes (LN) were removed 5 days later.
cross stimulation with serial dilutions of wt gp160 and
gp160A123 iscoms. In all strains of mice, both wt gp160
Proliferation assay and gp160A123 iscoms efficiently primed LN cells which
proliferated in a dose-dependent manner after stimula-
Single cell suspensions were prepared from draining tion in vitro with the homologous iscoms (Figs. 1a–1c).
LN and 100 ml/well (2.5 1 106 LN cells/ml) was mixed Restimulation of these LN cells with the heterologous
with an equal volume of dilutions of antigen in triplicate. iscom preparation induced proliferative responses of
Antigens used for restimulation were wt gp160 and magnitudes similar to those obtained after stimulation
gp160A123 in iscoms (final concentrations 0.008 to 0.2 mg/ with the iscoms used for immunization. Thus, the ability
ml) and the synthetic peptides listed in Table 1 (final of gp160A123 iscoms to prime T cells in vivo as well asconcentrations 2.5 to 20 mg/ml). The culture medium was to stimulate sensitized T cells in vitro was comparable
Iscove’s medium (National Veterinary Institute, Uppsala, to that of wt gp160.
Sweden) supplemented with 2 mM L-glutamine, 50 mM b-
mercaptoethanol, 50 mg/ml gentamicin, and 0.5% normal Specificity of T cell responses to wt gp160
mouse serum. After 4 days of culture, 1 mCi/well of [3H]- and gp160A123thymidine was added and the cells were harvested 16 hr
later. Thymidine incorporation was determined by liquid For analysis of the specificity of the T cell responses,
LN cells from C57BL/6, BALB/c, and CBA mice immu-scintillation and is expressed as cpm values corrected
for background by subtracting the values of culture me- nized with wt gp160 or gp160A123 iscoms were stimulated
in vitro with 13 synthetic peptides representing selecteddium controls.
/ m4777$7660 01-09-96 12:02:02 viral AP-Virology
127GLYCANS AFFECT T CELL RESPONSES TO HIV-1 gp160
et al., 1991). Further, peptides 31, 32, 35, 36, and 37
cover the three N-glycosylation sites deleted in the CD4-
binding domain of the mutated gp160A123 . LN cells from
BALB/c mice primed with either wt gp160 or gp160A123
iscoms were stimulated to proliferate with the peptides
15 and 16 (Fig. 2a) and cells from CBA mice were acti-
vated by peptide 8 (Fig. 2b). LN cells from C57BL/6 mice
immunized with either wt gp160 or gp160A123 iscoms also
proliferated after stimulation with the peptides 15 and 16
(Fig. 2c). Considering the comparatively large size and
overlap of the peptides, it is possible that stimulated LN
cells from BALB/c and C57BL/6 mice responded to an
epitope present in both peptides 15 and 16. However, in
C57BL/6 mice, wt gp160 iscoms also activated LN cells
which responded in vitro to peptide 35, whereas cells
primed with gp160A123 iscoms failed to recognize this
peptide (Fig. 2c). The latter observation was confirmed
in experiments where serial dilutions of the peptides 15,
16, and 35 were used for restimulation. As can be seen
in Figs. 3a–3c, LN cells from C57BL/6 mice immunized
with wt gp160 iscoms were stimulated in vitro in a dose-
dependent manner by all 3 peptides. Peptides 15 and 16
also induced a dose-dependent proliferative response in
LN cells primed with gp160A123 iscoms (Figs. 3a and 3b),
whereas these cells were unable to respond to peptide
35 (Fig. 3c). This pattern of response to the peptides 15,
16, and 35 after immunization of C57BL/6 mice with wt
gp160 or gp160A123 iscoms was observed in three inde-
pendent experiments even though individual values oc-
casionally varied (data not shown).
The importance of Asn448 for T cell recognition
Asn448 is associated with the second N-glycosylation
site deleted in gp160A123 and is also included in peptide
35. To investigate whether the lack of T cell response to
peptide 35 in C57BL/6 mice immunized with gp160A123
iscoms was due to the substitution of Asn448 by Gln in
the mutated protein, peptides 35, mG5, and m67 were
compared for their capacity to restimulate LN cells
primed with wt gp160 or gp160A123 iscoms. The peptides
FIG. 1. Analysis of T cell responses to wt gp160 and gp160A123 . mG5 and m67 are identical to peptide 35 at all amino
Proliferative responses of LN cells from BALB/c (a), CBA (b), and C57BL/ acid positions except Asn448 , which has been changed6 (c) mice immunized with wt gp160 (solid line) or gp160A123 iscoms to Gln in peptide mG5 and Gly in peptide m67 (Table 1).(dotted line). LN cells were stimulated in vitro with dilutions of wt gp160
All three peptides induced comparable dose-dependent(m) or gp160A123 iscoms (s). Values represent the arithmetic mean {
SEM of triplicate cultures. The [3H]thymidine incorporations of culture proliferative responses in LN cells from mice immunized
medium controls were 1342 { 318 and 4878 { 563 (a), 347 { 39 and with wt gp160 iscoms (Figs. 4a–4c). These responses
320 { 1 (b), and 634 { 70 and 394 { 31 (c) after immunization with were significantly higher than those obtained after similar
wt gp160 and gp160A123 in iscoms, respectively. Similar results were restimulations of LN cells primed with gp160A123 iscomsobtained in three additional experiments.
(P  0.05). The ability of these latter cells to respond
to the peptides was in general low and displayed no
statistically significant dose dependency (P 0.05) (Figs.parts of the gp120 sequence (numbered 7 to 39 in Table
1). These peptides cover HIV-1/gp120 regions known to 4a–4c). It is less likely that this weak response was the
result of an overall diminished T cell response tobe associated with the induction of neutralizing antibod-
ies, including the V3 region and the CD4-binding domain gp160A123 since no significant difference in proliferation
between LN cells primed with wt gp160 or gp160A123(Fung et al., 1992; Ho et al., 1988, 1991b; Javaherian et
al., 1989; Kang et al., 1991; Matthews et al., 1986; Steimer iscoms was observed after restimulation with homolo-
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to a Gln per se was not causing the lack of T cell re-
sponse to peptide 35.
T cell responses to deglycosylated wt gp160 iscoms
The importance of the N-linked oligosaccharide chains
for the generation of T cell responses to peptide 35 in
C57BL/6 mice was further analyzed in proliferation exper-
FIG. 2. Analysis of the specificity of T cell responses to wt gp160
and gp160A123 . Proliferative responses of LN cells from BALB/c (a),
CBA (b), and C57BL/6 (c) mice immunized with wt gp160 (j) or
gp160A123 iscoms (h). LN cells were stimulated in vitro with 20 mg/ml
of the peptides 7 to 39. Values represent the arithmetic mean{ SEM of
triplicate cultures. The [3H]thymidine incorporations of culture medium
controls were 661 { 359 and 401 { 98 (a), 403 { 56 and 474 { 39
FIG. 3. Proliferative responses to the peptides 15 (a), 16 (b), and 35(b), and 1430 { 331 and 1365 { 564 (c) after immunization with wt
(c) of LN cells from C57BL/6 mice immunized with wt gp160 (m) orgp160 and gp160A123 in iscoms, respectively.
gp160A123 iscoms (s). LN cells in triplicate cultures were stimulated in
vitro with dilutions of the peptides. Values represent the mean of twogous and heterologous gp160 or with peptide 15 (P 
independent experiments and are expressed as the arithmetic mean
0.05, data not shown). Thus, the stimulatory activity in of [3H]thymidine incorporation { SEM. The [3H]thymidine incorporation
vitro of the peptides mG5 and m67 was comparable to of culture medium controls was 854 { 600 for wt gp160 iscoms and
661 { 300 for gp160A123 iscoms.that of peptide 35, indicating that the exchange of Asn448
/ m4777$7660 01-09-96 12:02:02 viral AP-Virology
129GLYCANS AFFECT T CELL RESPONSES TO HIV-1 gp160
a-mannose, was markedly reduced (data not shown). It
should be noted that even though a substantial fraction
of N-linked oligosaccharide chains were removed from
gp160, deglycosylation was most likely not complete un-
der the present experimental conditions, i.e., without SDS
treatment, boiling, and reduction. These conditions were
chosen in order to maintain the three-dimensional struc-
ture of gp160 (Fenouillet et al., 1989). To ensure that
possible conformation changes were caused by deglyco-
sylation and not by the enzymatic digestion conditions,
control gp160 iscoms were treated in the same way with-
out addition of N-glycosidase F. In general, T cell re-
sponses to deglycosylated gp160 were comparable to
responses to fully glycosylated control gp160. Thus, LN
cells from C57BL/6 mice immunized with deglycosylated
gp160 in iscoms responded in vitro to fully glycosylated
control gp160 iscoms and also recognized peptides 15
and 16 in a pattern similar to that of cells primed with
wt gp160 iscoms (data not shown). However, in line with
the results obtained with gp160A123 iscoms, deglycosy-
lated gp160 in iscoms failed to prime LN cells that re-
sponded to peptide 35 in vitro (Fig. 6). This lack of re-
sponse was not a consequence of the mild nondenatur-
ing conditions used in the glycosidase digestion since
LN cells from mice immunized with fully glycosylated
control gp160 iscoms were restimulated to proliferate
with peptide 35 (Fig. 6).
DISCUSSION
In the present study we have identified in mice a carbo-
hydrate-dependent T cell epitope in the C-terminal CD4-
binding domain of the HIV-1 envelope protein gp160.
Several recent studies suggest that glycosylation may
constrain or abrogate T cell recognition of viral antigens
(Botarelli et al., 1991; Doe et al., 1994; Drummer et al.,
1993; Jackson et al., 1994). In contrast, we demonstrate
that defined N-linked glycans in the vicinity of this epitope
has the opposite function, i.e., they participate in, and
are indeed indispensable for, T cell recognition and in-
duction of the T cell response. This conclusion is based
on the following results. First, T cells from H-2b miceFIG. 4. Proliferative responses to the peptides mG5 (a), m67 (b), and
35 (c) of LN cells from C57BL/6 mice immunized with wt gp160 (m) or primed in vivo with mutated gp160 (gp160A123), lacking
gp160A123 iscoms (s). LN cells were stimulated in vitro with dilutions
of the peptides. Values are expressed as the arithmetic mean of [3H]-
thymidine incorporation { SEM of triplicate cultures. The [3H]thymidine
incorporation of culture medium controls was 1275 { 341 for wt gp160
iscoms and 488 { 49 for gp160A123 iscoms.
iments using wt gp160 iscoms enzymatically deglycosy-
lated with N-glycosidase F. This enzyme hydrolyzes both
complex and high-mannose types of N-linked oligosac-
FIG. 5. The effect of deglycosylation with N-glycosidase F on thecharide chains at the glycosyl–amine junction of aspara-
apparent molecular weight (Mw) of wt gp160 in iscom. Western blotgine residues which are converted to aspartic acid (Tar-
analysis of native wt gp160 iscoms (lane 1) and deglycosylated gp160 inentino et al., 1985). Western blot analysis revealed that
iscoms (lane 2). The position of gp160 was identified with a monoclonal
the apparent molecular weight of N-glycosidase F- antibody reactive with the V3 region of gp120. Lane Mw shows the
treated wt gp160 was reduced to approximately 110 kDa position of molecular weight marker proteins (Sigma) stained with Coo-
massie brilliant blue.(Fig. 5) and that binding of the lectin Con A, specific for
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Ishioka et al., 1992). Further, an O-linked glycan on a
naturally glycosylated immunodominant peptide of type
II collagen has been reported to be involved in the inter-
action between TCR, peptide, and MHC class II mole-
cules (Michae¨lsson et al., 1994). However, a similar func-
tion of the glycan associated with Asn448 is unlikely since
T cells primed with wt gp160 were activated in vitro by
peptide 35, which lacks glycans. Moreover, peptide 36,
which contains the C-terminal part of peptide 35 includ-
ing Asn448 (see Table 1), failed to restimulate T cells
primed with wt gp160 and substitution of Asn448 to a Gln
or Gly did not affect the stimulatory capacity of peptide
35. These findings indicate that Asn448 and the glycan
associated with it in wt gp160 are not critical for T cell
FIG. 6. Proliferative responses to peptide 35 of LN cells from C57BL/
recognition and are most likely not part of the T cell6 mice immunized with wt (m) or deglycosylated gp160 in iscoms (h).
determinant in peptide 35.LN cells were stimulated in vitro with dilutions of the peptide. Values
are expressed as the arithmetic mean of [3H]thymidine incorporation An alternative role of the deleted glycans in the induc-
{ SEM of triplicate cultures. The [3H]thymidine incorporation of culture tion of T cell responses to peptide 35 relates to the fact
medium controls was 1186 { 458 for wt gp160 iscoms and 1139 { that the presence or absence of glycans can alter the
388 for deglycosylated gp160 iscoms. Similar results were obtained in
proteolytic susceptibility of viral proteins (Klenk, 1980;two additional experiments.
Sodora et al., 1991). Thus, the deletion of three glycans
may have induced a change in the three-dimensional
structure of gp160A123 resulting in altered accessibility tothe three glycans, were unable to respond in restimula-
tion experiments to this determinant represented by the proteolytic enzymes and thereby masking of the T cell
determinant. Alternatively, altered protein conformationpeptide 35 (amino acids 430–453). Second, enzymati-
cally deglycosylated wt gp160 failed to induce a T cell may have revealed hidden cleavage sites within the de-
terminant resulting in destruction of the T cell epitoperesponse to peptide 35. On the other hand, wt gp160
and gp160A123 induced comparable T cell responses to following exposure to proteolytic enzymes. However, the
finding that wt gp120 in Freund’s complete adjuvant in-determinants which, with respect to the secondary struc-
ture of gp160, are located distant from the position of duced a T cell response to peptide 35 even after denatur-
ation of the protein by treatment with SDS, boiling, andthe deleted glycans. This finding was consistent in three
tested haplotypes of mice. Thus, elimination of three gly- reduction of disulfide bonds argues against this view
(S. Sjo¨lander et al., unpublished results). A more likelycans does not affect T cell responses to distant epitopes
but abrogates priming of T cells recognizing a determi- explanation is that the bulky N-linked glycans sterically
hinder access of proteolytic enzymes to cleavage sitesnant in close proximity to the deletion sites, indicating
that glycans may be essential for the generation of cer- within the T cell determinant, thus protecting it from de-
struction. Indeed, the amino acid sequence MYAP (aminotain T cell specificities. However, it is not self-evident in
which way glycans may influence T cell responses since acids 434–437), which is present in gp160 and peptide
35, has been suggested to constitute a potential cleav-deglycosylation can also enhance T cell recognition. Bo-
tarelli et al. (1991) have, for example, found that 20% of age site for cathepsin B (Mouritzen et al., 1991), a lyso-
somal protease reported to be involved in the proteolytichuman CD4/ T cell clones specific for nonglycosylated
gp120 fail to recognize glycosylated gp120. Likewise, de- degradation of antigens. Consequently, deletion of the
glycans may have resulted in proteolytic degradation ofglycosylation of influenza virus hemagglutinin has been
reported to reveal determinants recognized by T cell the epitope during antigen processing of gp160A123 . In
contrast, the nonglycosylated peptide 35 is most likelyclones (Drummer et al., 1993) and addition of a heptasac-
charide to a peptide comprising such an epitope elimi- able to bind to MHC class II molecules without pro-
cessing, thus preventing destruction of the T cell determi-nated its T cell stimulatory capacity (Jackson et al., 1994).
There are several ways by which the glycans in the nant.
Both wt gp160 and gp160A123 induced a strong total TCD4-binding domain of gp160 may influence the induc-
tion of T cells reactive to the determinant in peptide 35. cell response in mice of the H-2b, H-2d, and H-2k haplo-
types. Moreover, LN cells primed with either of the pro-In this context, the presence of Asn448 in peptide 35 is
crucial since it is associated with one of the glycosylation teins were efficiently stimulated in vitro with both the
homologous and the heterologous gp160. These resultssites deleted in gp160A123 . It has recently been demon-
strated by the use of synthetic glycopeptides that glycans indicate that even though deletion of the N-glycans influ-
enced the recognition of a specific T cell epitope, themay influence the binding of peptides to MHC class II
molecules and that they also may be part of the antigenic overall immunogenic and antigenic properties of
gp160A123 were minimally affected. However, it is possi-determinant recognized by T cells (Harding et al., 1993;
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Benjouad, A., Gluckman, J. C., Rochat, H., Montagnier, L., and Bahroui,ble that a more extensive deglycosylation involving N-
E. (1992). Influence of carbohydrate moieties on the immunogenicityglycans in other regions may induce profound alterations
of human immunodeficiency virus type 1 recombinant gp160. J. Virol.
of T cell responses to HIV glycoproteins. This assumption 66, 2473–2483.
is supported by results showing that induction of CD8/ Bolmstedt, A., Hemming, A., Flodby, P., Berntsson, P., Travis, B., Lin,
J. P. C., Ledbetter, J., Tsu, T., Wigzell, H., Hu, S.-L., and Olofsson, S.cytotoxic T lymphocyte responses in mice are more effi-
(1991). Effects of mutations in glycosylation sites and disulphidecient with completely deglycosylated gp120 than with
bonds on processing, CD4-binding and fusion activity of human im-the fully glycosylated protein (Doe et al., 1994). Further,
munodeficiency virus envelope glycoproteins. J. Gen. Virol. 72, 1269–
nonglycosylated gp120 primed CD4/ T cells in humans 1277.
which are unable to recognize the native protein (Bota- Bolmstedt, A., Olofsson, S., Sjo¨gren-Jansson, E., Jeansson, S., Sjo¨blom,
I., A˚kerblom, L., Hansen, J.-E. S., and Hu, S.-L. (1992). Carbohydraterelli et al., 1991).
determinant NeuAc-Galb(1-4) of N-linked glycans modulates the anti-Recent results suggest that antibodies raised to either
genic activity of human immunodeficiency virus type 1 glycoproteinwt gp160 or gp160A123 more efficiently neutralize HIV-1 gp120. J. Gen. Virol. 73, 3099–3105.
virus expressing the homologous envelope protein Botarelli, P., Houlden, B. A., Haigwood, N. L., Servis, C., Montagna, D.,
(Bolmstedt et al., unpublished results). This preferred ho- and Abrignani, S. (1991). N-glycosylation of HIV-gp120 may constrain
recognition by T lymphocytes. J. Immunol. 147, 3128–3132.mologous neutralization indicates that the wt gp160 and
Dalgleish, A. G., Beverly, P. C., Clapham, P. R., Crawford, D. H., Greaves,gp160A123 expose partially differing B cell epitopes. In
M. F., and Weiss, R. A. (1984). The CD4 (T4) antigen is an essentialthis study, we have shown that deletion of three N-linked
component of the receptor for the AIDS retrovirus. Nature 312, 763–
glycans in the CD4-binding domain of gp160A123 abro- 767.
gates the in vivo priming of T cells recognizing a determi- Doe, B., Steimer, K. S., and Walker, C. M. (1994). Induction of HIV-1
envelope (gp120)-specific cytotoxic T lymphocyte responses in micenant present in this part of the wt protein. The implica-
by recombinant CHO cell-derived gp120 is enhanced by enzymatictions of these results for immune protection to HIV infec-
removal of N-linked glycans. Eur. J. Immunol. 24, 2369–2376.tion are not clear. However, they suggest a possible
Doms, R. W., Lamb, R. A., Rose, J. K., and Helenius, A. (1993). Folding
mutation strategy for elimination of B and/or T cell epi- and assembly of viral membrane proteins. Virology 193, 545–562.
topes to escape immune pressure, a view supported by Drummer, H. E., Jackson, D. C., and Brown, L. E. (1993). Modulation of
the finding that the deletion of three glycans in gp160A123 CD4/ T-cell recognition of influenza hemagglutinin by carbohydrate
side chains located outside a T-cell determinant. Virology 192, 282–does not affect virus replication (Olofsson et al., unpub-
289.lished results). The results also highlight the importance
Eriksson, K., Horal, P., Svennerholm, B., Jeansson, S., Vahlne, A., Holm-of appropriate glycosylation in the design of glycosylated
gren, J., and Czerkinsky, C. (1993). Systemic identification of T-cell
vaccine antigens, in particular since viral proteins pro- activating epitopes on the human immunodeficiency virus type 1
duced in prokaryotic and certain eukaryotic expression envelope glycoprotein gp120 in primates immunized with synthetic
peptides. Vaccine 11, 859–865.systems are subjected to no or only restricted glycosyla-
Fenouillet, E., Clerget-Raslain, B., Gluckman, J. C., Gue´tard, D., Montag-tion (Kukuruzinska et al., 1987; Lechner, 1989).
nier, L., and Bahraoui, E. (1989). Role of N-linked glycans in the
interaction between the envelope glycoprotein of human immunode-
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